Page Header

  • Home
  • About
  • Login
  • Register
  • search
  • Current
  • Archives
  • Submissions
  • Announcements
  • TTUHSC Pulmonary Video Series
  • Grand Rounds
Home / Vol 5, No 19 (2017) Gavidia Quezada

Diabetic ketoacidosis: Should current management include subcutaneous insulin injections?

Rocio Gavidia Quezada, Hawa Edriss

Abstract


Diabetic ketoacidosis is a well-known acute complication in patients with both type 1 and
type 2 diabetes mellitus. Although mortality has decreased considerably, it remains an important
cause for admission to intensive care units. Medical management includes intravenous fluid
therapy, insulin, correction of electrolyte abnormalities, and addressing the precipitating factor
which in most cases is infection or non-compliance with insulin therapy. Usually patients with
diabetic ketoacidosis are admitted to the intensive care unit for continuous infusion of insulin;
however, the development of rapid acting insulin analogues has made it possible to treat
mild to moderate diabetic ketoacidosis with subcutaneous insulin. Although studies using
subcutaneous insulin include only a small number of patients, this approach seems as effective
as intravenous insulin infusions in patients with mild to moderate diabetic ketoacidosis. Diabetic
education and close follow-up for patients admitted for diabetic ketoacidosis remain essential
to avoid recurrence and readmissions.
Keywords: Diabetic ketoacidosis, acute complication in diabetes, rapid acting insulin
analogues, subcutaneous insulin in diabetic ketoacidosis


References


Powers AC. Harrison’s Principles of Internal Medicine 17th

edition, Chapter 338, Diabetes Mellitus, Diabetes Ketoacidosis

Pathophysiology, p 2283.

Wang J, Williams DE, Narayan KM, Geiss LS. Declining death

rates from hyperglycemic crisis among adults with diabetes,

US 1985-2002. Diabetes Care 2006 Sep; 29(9):2018-22.

Nyenwe EA, Kitabchi AE. The Evolution of diabetic ketoacidosis:

An update of its etiology, pathogenesis and management.

Division of Endocrinology, Diabetes and Metabolism,

University of Tennessee Health Science Center. https://doi.

org/10.1016/j.metabol.2015.12.007. Published: 2016-04.

Dhatariya K. Diabetic emergencies. Diabetic Ketoacidosis

and Hyperosmolar Crisis in Adults. Medicine; 42 (12):

p723-726. [published online: October 20, 2014].

Munro JF, Cambell IW, McCuish AC et al. Euglycemic diabetic

ketoacidosis. Br. Med J 1973; 2(5866):578–80.

Burge MR, Hardy KJ, Schade DS. Short-term fasting is a

mechanism for the development of euglycemic ketoacidosis

during periods of insulin deficiency. J Clin Endocrinol

Metab 1993; 76(5):1192–8.

Juarez Ramirez Tello E, Orellana-Barrios M, Nugent K.

Sodium-glucose co-transporter 2 inhibitor induced diabetic

ketoacidosis in a type 2 diabetic patient. Amer J Med Sci;

(6): 634-635.

Peters AL, Buschur EO, Buse JB, et al. Euglycemic diabetic

ketoacidosis: A potential complication of treatment with

sodium–glucose cotransporter 2 inhibition. Diabetes Care

Sep; 38(9): 1687-1693.

Taylor SI, Blau JE, Rother KI. Perspective: SGLT2 inhibitors

may predispose to ketoacidosis. J Clin Endocrinol

Metab 2015 Aug; 100 (8):2849-52.

Hyperglycemic Crises in Diabetes. American Diabetes Association.

Diabetes Care 2004. Jan; 27(Supplement 1): s94-s102.

Bratusch-Marrain PR, Komajati M, Waldhausal W. The

effect of hyperosmolarity on glucose metabolism. Pract Cardiol

; 11:153–63.

Waldhausl W, Kleinberger G, Korn A, et al. Severe hyperglycemia:

effects of rehydration on endocrine derangements

and blood glucose concentration. Diabetes 1979; 28:577–84.

Martin HE, Smith K, Wilson ML. The fluid and electrolyte

therapy of severe diabetic acidosis and ketosis; a study of

twenty-nine episodes (twenty-six patients). Am J Med 1958;

:376–89.

Doshi P, Potter A, De Los Santos D, Banuelos R, Darger

B, Chathampally Y. Prospective randomized trial of insulin

glargine in acute management of diabetic ketoacidosis in the

emergency department: a pilot study. Academic Emergency

Medicine 2015; 22:658–662.

Umpierrez G, Cuervo R, Karabell A, Latif K, Freire A,

Kitabchi A. Treatment of diabetic ketoacidosis with subcutaneous

insulin aspart. Diabetes Care 2004 Aug; 27(8): 1873-

http://dx.doi.org/10.2337/diacare.27.8.1873

Ersöz HO, Ukinc K, Köse M, et al. Subcutaneous Lispro

and intravenous regular insulin treatments are equally effective

and safe for the treatment of mild and moderate diabetic

ketoacidosis in adult patients. Int J Clin Pract 2006;

:429–33.

Miller DW, Slovis CM. Hypophosphatemia in the emergency

department therapeutics. Am J Emerg Med 2000; 18:457–61.

Duhon B, Attridge RL, Franco-Martinez AC, Maxwell PR,

Hughes DW. Intravenous sodium bicarbonate therapy in

severely acidotic diabetes ketoacidosis. Ann Pharmacother

(7-8):970-5. [Epub 2013 Jun 4].

American Diabetes Association. Diabetes Care in the Hospital,

Insulin therapy, transitioning to subcutaneous insulin

Jan; 40(Supplement 1): S120-S127. https://doi.

org/10.2337/dc17-S017

Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy

in severe diabetic ketoacidosis. Ann Intern Med 1986; 105:

– 840.


Full Text: ABSTRACT FULL TEXT PDF

DOI: 10.12746/swrccc.v5i19.389

Refbacks

  • There are currently no refbacks.

ISSN: 2325-9205

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

The Southwest Respiratory and Chrictical Care Chronicles

 Vol 6, Iss 22

Figure 1

 

Image Challenge

Figure 2

A 54-year-old obese woman with a history of cardioverter defibrillator implantation (ICD) in 2004 for symptomatic ventricular tachycardia presented with discomfort at the site of the pulse generator and a “feeling of a knot”. 

Click here to read the full case

User
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Managed Hosting, Support, and OJS Responsive Theme by:
OpenJournalSystems.com